OMEGA OPHTHALMICS
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1848-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
4
Active:1
Completed:3
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (100.0%)Clinical Investigation of Omega Refractive Capsule Model V With Use of an FDA Approved IOL
Not Applicable
Completed
- Conditions
- Cataract
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Omega Ophthalmics
- Target Recruit Count
- 6
- Registration Number
- NCT04574102
- Locations
- 🇨🇷
Clinica 20/20, San José, Costa Rica
Clinical Investigation of Omega Refractive Capsule, Model VI
Not Applicable
Active, not recruiting
- Conditions
- Cataract
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Omega Ophthalmics
- Target Recruit Count
- 30
- Registration Number
- NCT04574115
- Locations
- 🇨🇷
Clinica 20/20, San José, Costa Rica
Comparison of Gemini III Rev 2 Implanted in Conjunction With an Approved IOL vs Eyes Implanted With an Approved IOL
Not Applicable
Completed
- Conditions
- Cataract
- First Posted Date
- 2019-08-16
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Omega Ophthalmics
- Target Recruit Count
- 6
- Registration Number
- NCT04059796
- Locations
- 🇨🇷
Clinica 20/20, San José, Costa Rica
Clinical Investigation of OMEGA Gemini Capsule, Model Gemini IV With an Approved Monofocal or Toric IOL
Not Applicable
Completed
- Conditions
- Cataract
- First Posted Date
- 2019-08-15
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Omega Ophthalmics
- Target Recruit Count
- 6
- Registration Number
- NCT04058314
- Locations
- 🇨🇷
Clinica 20/20, San José, Costa Rica
News
No news found